ACTRN12624000819527RecruitingUnknown
POST-IT: A randomised controlled trial to evaluate a POSTpartum Intervention to support adherence to recommended Testing in women diagnosed with gestational diabetes and hypertensive disorders
Prof Michelle Giles, Department of Obstetrics, Monash Health, 246 Clayton Road, Melbourne, Vic 31680 sites144 target enrollmentStarted: July 3, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 144
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Diagnosis
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to 55 Years (—)
- Sex
- Female
Inclusion Criteria
- •Planning to receive all antenatal care at site of study recruitment
- •Diagnosed with HDP or GDM at any point during pregnancy
Exclusion Criteria
- •Aged <18 years
- •Past history of hypertension, Type 1 or Type 2 diabetes or Mature Onset Diabetes of the Young (MODY) that predates current pregnancy and for which they receive long term healthcare follow up
- •Diagnosis of severe GDM or HDP with activation of alternative specialist postpartum pathways: endocrinologist (GDM with complex management needs or concern for pre-existing Type 1 diabetes or MODY); or nephrologist (severe pre-eclampsia, eclampsia, or Haemolysis/Elevated Liver enzymes/Low platelets HELLP syndrome).
- •Residence interstate/overseas and planning to complete postpartum care outside of Victoria.
- •Women who have had a fetal death in utero or stillbirth; if already recruited, then they will automatically be withdrawn from the study.
- •Women who have complex medical or psychiatric needs in the peripartum period requiring extended stay (> two weeks, or > one week in Intensive Care Unit) postpartum; or otherwise deemed unsuitable at the discretion of the researcher/clinician.
- •Women who are incarcerated, who do not speak English and there is no interpreter available to obtain consent
- •Women who give birth prior to 32 weeks where an alternate postpartum pathway is in situ for follow-up
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to compare effect of kushmand choornavati with Tagar ghanvati as anxiolytic and sedative as pre-medication in spinal anaesthesiaCTRI/2020/01/022835PDEAS College of Ayurved and research centre
Not yet recruiting
Unknown
A clinical trial to study the effects of two procedures, shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in patients with irregular menses and pcos.CTRI/2024/03/063784Chaitalee Rajendra Jain
Terminated
Phase 3
Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.SmokingMental illnessDrug and alcohol dependenceMental Health - AddictionMental Health - Other mental health disordersACTRN12616001355460The University of Auckland15
Recruiting
Phase 2
A trial examining the use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for children undergoing microlaryngoscopy and bronchoscopyRespiratory diseaseAnaesthesiology - AnaestheticsRespiratory - Other respiratory disorders / diseasesACTRN12617000799358Auckland District Health Board250
Completed
Not Applicable
A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancerCancerBreast cancerISRCTN83688026Royal Marsden Hospital (UK), secondary sponsor Schering (Germany)1,000